MACAN WILLIAM ANDREW 4
4 · Neuronetics, Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
MACAN WILLIAM ANDREW
EVP, CLO and CS
Transactions
- Sale
Common Stock
2024-02-28$3.16/sh−22,377$70,711→ 395,359 total - Award
Common Stock
2024-02-29+15,000→ 404,333 total - Sale
Common Stock
2024-02-29$2.94/sh−6,026$17,716→ 389,333 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit ("RSU") award.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.95 to $3.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Represents a RSU award that vests in three equal annual installments beginning on February 28, 2025, in each case subject to continuous service of the Reporting Person through such date.
- [F5]Each RSU represents a contingent right to receive one share of the Issuer's common stock.